ASX:CSLBiotechs
CSL (ASX:CSL) Valuation Check After A$1.5b Kankakee Expansion Commitment
CSL (ASX:CSL) has just committed A$1.5b to expand its Kankakee, Illinois manufacturing site, using its Horizon 2 process to lift plasma therapy output and add hundreds of U.S. jobs.
See our latest analysis for CSL.
Despite committing fresh capital to grow its U.S. footprint, CSL’s share price has faced pressure, with a 30 day share price return decline of 13.71% and a 1 year total shareholder return loss of 42.19%, suggesting recent news is being weighed against longer term concerns.
If CSL’s...